We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS
Read MoreHide Full Article
Shares of popular vaccine makers fell on Thursday after President-elect Donal Trump announced his decision to nominate vaccine skeptic Robert F. Kennedy Jr. to run the Department of Health and Human Services (“HHS”).
Though this nomination was officially confirmed on Trump’s social media accounts after market close, news reports of RFK Jr. having a prominent role in federal health agencieshave been circulating ever since Trump won the elections.
In a social media post, Kennedy accepted the offer and committed to advancing Trump’s vision to ‘Make America Healthy Again.’
Stocks That Fell Following the News
In response to the news, shares of Moderna (MRNA - Free Report) were down nearly 6%. Pfizer (PFE - Free Report) stock fell almost 3%. Shares of Novavax (NVAX - Free Report) and BioNTech (BNTX - Free Report) also lost 7% each. Shares of European drugmakers GSK and Sanofi also lost 2% and 3.4%, respectively.
Why are Markets Concerned About RFK Jr.’s Nomination?
Robert F. Kennedy Jr. is one of the most prominent anti-vaccine activists in the country and has been called out for spreading misinformation and false propaganda on vaccines. He is also the founder of the non-profit anti-vaccine organization Children’s Health Defense.
Investors have expressed concerns about the falling COVID-19 vaccination rates in the country, which has negatively impacted the top and bottom lines of Moderna, Pfizer, BioNTech and Novavax over the last couple of years.
Nominating RFK Jr. as the head of HHS might allow him to advance his anti-vaccine theories and even bring some major changes in public health policies. This could potentially discourage more American citizens from getting routine shots for COVID-19 and influenza. This could have a further denting impact on the financials of these vaccine-makers.
Kennedy was a candidate for the Presidential election this season before dropping out of the race and extending his support to Trump.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS
Shares of popular vaccine makers fell on Thursday after President-elect Donal Trump announced his decision to nominate vaccine skeptic Robert F. Kennedy Jr. to run the Department of Health and Human Services (“HHS”).
Though this nomination was officially confirmed on Trump’s social media accounts after market close, news reports of RFK Jr. having a prominent role in federal health agencieshave been circulating ever since Trump won the elections.
In a social media post, Kennedy accepted the offer and committed to advancing Trump’s vision to ‘Make America Healthy Again.’
Stocks That Fell Following the News
In response to the news, shares of Moderna (MRNA - Free Report) were down nearly 6%. Pfizer (PFE - Free Report) stock fell almost 3%. Shares of Novavax (NVAX - Free Report) and BioNTech (BNTX - Free Report) also lost 7% each. Shares of European drugmakers GSK and Sanofi also lost 2% and 3.4%, respectively.
Why are Markets Concerned About RFK Jr.’s Nomination?
Robert F. Kennedy Jr. is one of the most prominent anti-vaccine activists in the country and has been called out for spreading misinformation and false propaganda on vaccines. He is also the founder of the non-profit anti-vaccine organization Children’s Health Defense.
Investors have expressed concerns about the falling COVID-19 vaccination rates in the country, which has negatively impacted the top and bottom lines of Moderna, Pfizer, BioNTech and Novavax over the last couple of years.
Nominating RFK Jr. as the head of HHS might allow him to advance his anti-vaccine theories and even bring some major changes in public health policies. This could potentially discourage more American citizens from getting routine shots for COVID-19 and influenza. This could have a further denting impact on the financials of these vaccine-makers.
Kennedy was a candidate for the Presidential election this season before dropping out of the race and extending his support to Trump.